Industry
why Nurix Therapeutics Inc [NRIX] is a Good Choice for Investors After New Price Target of $23.91
Nurix Therapeutics Inc [NASDAQ: NRIX] closed the trading session at $15.69. The company report on April 10, 2024 at 7:00 AM that Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update. Extended the Strategic Collaboration with Gilead Sciences. Extended the
